TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Börse Stuttgart
Equities
2TZ
CNE100000924
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.214 EUR | -5.49% |
|
-6.80% | +22.04% |
| May. 15 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
Evolution of the average Target Price on Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
e51fa98.pkbzaf0ckcZp6Tawjx4rXHUh_KBwfLYcERiBw1vifyI._A6HI75LwpUGxHni-HNyOCFyt_AWUdQpUnf0my-WSHfFBYEbtSzwqyidZw~5c1fb308a87c7ef66aadfe66b90420f0
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
35.24
CNY
Average target price
45.8
CNY
Spread / Average Target
+29.97%
High Price Target
45.8
CNY
Spread / Highest target
+29.97%
Low Price Target
45.8
CNY
Spread / Lowest Target
+29.97%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- 2TZ Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
